Maribel Mcnaught

Alzheimer’s Lecanemab Treatment Up to 36 Months Supported by Extension Study

April 6, 2025

You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/aan/114987" on this server. Reference #18.4e5c417.1743987285.57dsrcb5 https://errors.edgesuite.net/18.4e5c417.1743987285.57dsrcb5 Read More

Maribel Mcnaught

Alzheimer’s Lecanemab Treatment Up to 36 Months Supported by Extension Study

The Best Workout Clothes for Men, Tested by Fitness Editors and Trainers

What Common Intervention Reduced Dementia Risk?

Uganda declares end of 6th Ebola outbreak

The US has nearly 900 measles cases, and 10 states have active outbreaks. Here’s what to know

Genetic medicine can leave people with rare mutations behind. But there’s new hope

New Medicare program could dramatically improve affordability for cancer drugs—if patients enroll

Brainomix partners with Medtronic to enhance stroke care

Datapharm collaborates with VIDAL to improve medicines information access in France

FDA cancels meeting of vaccine experts scheduled to advise on flu shots

Cauliflower pizza shells recalled because of plastic in product

Want to Try the Butter Churner Sex Position? Here’s How.

What Common Intervention Reduced Dementia Risk?

Uganda declares end of 6th Ebola outbreak

The US has nearly 900 measles cases, and 10 states have active outbreaks. Here’s what to know

Genetic medicine can leave people with rare mutations behind. But there’s new hope

New Medicare program could dramatically improve affordability for cancer drugs—if patients enroll

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories